Abstract
The goal of radiofrequency (RF) and cryoablation is to permanently damage cardiac tissue that sustains an arrythmia via thermal injury. Under-ablating tissue will cause ineffective lesion formation and arrhythmia recurrence, while over-ablating can lead to serious life-threatening complications. In this chapter, we review lesion biophysics and the ability of clinical parameters to predict lesion formation. Over the last decade, significant technological advancement in both cryoballoon and RF ablation technology has caused the electrophysiology community to wonder about the relative merits of each technology. Here, we compare the clinical safety, efficacy, and cost of these two energy sources for the treatment of atrial fibrillation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. J Arrhythm. 2017;33(5):369–409.
Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837–47.
Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Rev Cardiol. 2014;11(11):639–54.
Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659–66.
Pennes HH. Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol. 1948;1(2):93–122.
Gabriel C, Peyman A, Grant EH. Electrical conductivity of tissue at frequencies below 1 MHz. Phys Med Biol. 2009;54(16):4863–78.
Tsai JZ, Will JA, Hubbard-Van Stelle S, Cao H, Tungjitkusolmun S, Choy YB, et al. In-vivo measurement of swine myocardial resistivity. IEEE Trans Biomed Eng. 2002;49(5):472–83.
Bowman HF, Cravalho EG, Woods M. Theory, measurement, and application of thermal properties of biomaterials. Annu Rev Biophys Bioeng. 1975;4(00):43–80.
Simsek FG, Ulgen Y. Electrical impedance of human blood with and without anticoagulants in the beta-dispersion region. Conf Proc IEEE Eng Med Biol Soc. 2012;2012:3262–4.
Fallert MA, Mirotznik MS, Downing SW, Savage EB, Foster KR, Josephson ME, et al. Myocardial electrical impedance mapping of ischemic sheep hearts and healing aneurysms. Circulation. 1993;87(1):199–207.
Tungjitkusolmun S, Haemmerich D, Cao H, Tsai JZ, Choy YB, Vorperian VR, et al. Modeling bipolar phase-shifted multielectrode catheter ablation. IEEE Trans Biomed Eng. 2002;49(1):10–7.
Cao H, Speidel MA, Tsai JZ, Van Lysel MS, Vorperian VR, Webster JG. FEM analysis of predicting electrode-myocardium contact from RF cardiac catheter ablation system impedance. IEEE Trans Biomed Eng. 2002;49(6):520–6.
Nath S, Lynch C 3rd, Whayne JG, Haines DE. Cellular electrophysiological effects of hyperthermia on isolated guinea pig papillary muscle. Implications for catheter ablation. Circulation. 1993;88(4 Pt 1):1826–31.
Haines DE. The biophysics of radiofrequency catheter ablation in the heart: the importance of temperature monitoring. Pacing Clin Electrophysiol. 1993;16(3 Pt 2):586–91.
Wittkampf FH, Hauer RN, Robles de Medina EO. Control of radiofrequency lesion size by power regulation. Circulation. 1989;80(4):962–8.
Weiss C, Antz M, Eick O, Eshagzaiy K, Meinertz T, Willems S. Radiofrequency catheter ablation using cooled electrodes: impact of irrigation flow rate and catheter contact pressure on lesion dimensions. Pacing Clin Electrophysiol. 2002;25(4 Pt 1):463–9.
Sulkin MS, Laughner JI, Hilbert S, Kapa S, Kosiuk J, Younan P, et al. Novel measure of local impedance predicts catheter-tissue contact and lesion formation. Circ Arrhythm Electrophysiol. 2018;11(4):e005831.
Yokoyama K, Nakagawa H, Shah DC, Lambert H, Leo G, Aeby N, et al. Novel contact force sensor incorporated in irrigated radiofrequency ablation catheter predicts lesion size and incidence of steam pop and thrombus. Circ Arrhythm Electrophysiol. 2008;1(5):354–62.
Straube F, Dorwarth U, Pongratz J, Bruck B, Wankerl M, Hartl S, et al. The fourth cryoballoon generation with a shorter tip to facilitate real-time pulmonary vein potential recording: feasibility and safety results. J Cardiovasc Electrophysiol. 2019;30(6):918–25.
Iacopino S, Pieragnoli P, Arena G, Sciarra L, Landolina M, Manfrin M, et al. A comparison of acute procedural outcomes within four generations of cryoballoon catheters utilized in the real-world multicenter experience of 1STOP. J Cardiovasc Electrophysiol. 2020;31(1):80–8.
Su W, Kowal R, Kowalski M, Metzner A, Svinarich JT, Wheelan K, et al. Best practice guide for cryoballoon ablation in atrial fibrillation: the compilation experience of more than 3000 procedures. Heart Rhythm. 2015;12(7):1658–66.
Lustgarten DL, Keane D, Ruskin J. Cryothermal ablation: mechanism of tissue injury and current experience in the treatment of tachyarrhythmias. Prog Cardiovasc Dis. 1999;41(6):481–98.
Holman WL, Ikeshita M, Douglas JM Jr, Smith PK, Cox JL. Cardiac cryosurgery: effects of myocardial temperature on cryolesion size. Surgery. 1983;93(2):268–72.
Mikat EM, Hackel DB, Harrison L, Gallagher JJ, Wallace AG. Reaction of the myocardium and coronary arteries to cryosurgery. Lab Investig. 1977;37(6):632–41.
Harrison L, Gallagher JJ, Kasell J, Anderson RH, Mikat E, Hackel DB, et al. Cryosurgical ablation of the A-V node-His bundle: a new method for producing A-V block. Circulation. 1977;55(3):463–70.
Mazur P. Cryobiology: the freezing of biological systems. Science. 1970;168(3934):939–49.
Gill W, Fraser J, Carter DC. Repeated freeze-thaw cycles in cryosurgery. Nature. 1968;219(5152):410–3.
Stewart GJ, Preketes A, Horton M, Ross WB, Morris DL. Hepatic cryotherapy: double-freeze cycles achieve greater hepatocellular injury in man. Cryobiology. 1995;32(3):215–9.
Wissner E, Heeger CH, Grahn H, Reissmann B, Wohlmuth P, Lemes C, et al. One-year clinical success of a ‘no-bonus’ freeze protocol using the second-generation 28 mm cryoballoon for pulmonary vein isolation. Europace. 2015;17(8):1236–40.
Tebbenjohanns J, Hofer C, Bergmann L, Dedroogh M, Gaudin D, von Werder A, et al. Shortening of freezing cycles provides equal outcome to standard ablation procedure using second-generation 28 mm cryoballoon after 15-month follow-up. Europace. 2016;18(2):206–10.
Kuck KH, Furnkranz A, Chun KR, Metzner A, Ouyang F, Schluter M, et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur Heart J. 2016;37(38):2858–65.
Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16):1713–23.
Shah DC, Lambert H, Nakagawa H, Langenkamp A, Aeby N, Leo G. Area under the real-time contact force curve (force-time integral) predicts radiofrequency lesion size in an in vitro contractile model. J Cardiovasc Electrophysiol. 2010;21(9):1038–43.
Neuzil P, Reddy VY, Kautzner J, Petru J, Wichterle D, Shah D, et al. Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ Arrhythm Electrophysiol. 2013;6(2):327–33.
Kautzner J, Neuzil P, Lambert H, Peichl P, Petru J, Cihak R, et al. EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation. Europace. 2015;17(8):1229–35.
Ullah W, Hunter RJ, Finlay MC, McLean A, Dhinoja MB, Sporton S, et al. Ablation index and surround flow catheter irrigation: impedance-based appraisal in clinical ablation. JACC Clin Electrophysiol. 2017;3(10):1080–8.
Das M, Loveday JJ, Wynn GJ, Gomes S, Saeed Y, Bonnett LJ, et al. Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values. Europace. 2017;19(5):775–83.
Hussein A, Das M, Riva S, Morgan M, Ronayne C, Sahni A, et al. Use of ablation index-guided ablation results in high rates of durable pulmonary vein isolation and freedom from arrhythmia in persistent atrial fibrillation patients. Circ Arrhythm Electrophysiol. 2018;11(9):e006576.
Phlips T, Taghji P, El Haddad M, Wolf M, Knecht S, Vandekerckhove Y, et al. Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the ‘CLOSE’-protocol. Europace. 2018;20(Fi_3):f419–f27.
Taghji P, El Haddad M, Phlips T, Wolf M, Knecht S, Vandekerckhove Y, et al. Evaluation of a strategy aiming to enclose the pulmonary veins with contiguous and optimized radiofrequency lesions in paroxysmal atrial fibrillation: a pilot study. JACC Clin Electrophysiol. 2018;4(1):99–108.
Tofig BJ, Lukac P, Nielsen JM, Hansen ESS, Tougaard RS, Jensen HK, et al. Radiofrequency ablation lesions in low-, intermediate-, and normal-voltage myocardium: an in vivo study in a porcine heart model. Europace. 2019;21:1919.
Viles-Gonzalez JF, Berjano E, d’Avila A. Complications of radiofrequency catheter ablation: can we prevent steam pops? JACC Clin Electrophysiol. 2018;4(4):501–3.
Reichlin T, Knecht S, Lane C, Kuhne M, Nof E, Chopra N, et al. Initial impedance decrease as an indicator of good catheter contact: insights from radiofrequency ablation with force sensing catheters. Heart Rhythm. 2014;11(2):194–201.
Chinitz JS, Kapur S, Barbhaiya C, Kumar S, John R, Epstein LM, et al. Sites with small impedance decrease during catheter ablation for atrial fibrillation are associated with recovery of pulmonary vein conduction. J Cardiovasc Electrophysiol. 2016;27(12):1390–8.
Rozen G, Ptaszek L, Zilberman I, Cordaro K, Heist EK, Beeckler C, et al. Prediction of radiofrequency ablation lesion formation using a novel temperature sensing technology incorporated in a force sensing catheter. Heart Rhythm. 2017;14(2):248–54.
Gaspar T, Sih H, Hindricks G, Eitel C, Sommer P, Kircher S, et al. Use of electrical coupling information in AF catheter ablation: a prospective randomized pilot study. Heart Rhythm. 2013;10(2):176–81.
Martin CA, Martin R, Gajendragadkar PR, Maury P, Takigawa M, Cheniti G, et al. First clinical use of novel ablation catheter incorporating local impedance data. J Cardiovasc Electrophysiol. 2018;29(9):1197–206.
Neumann T, Vogt J, Schumacher B, Dorszewski A, Kuniss M, Neuser H, et al. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol. 2008;52(4):273–8.
Ghosh J, Martin A, Keech AC, Chan KH, Gomes S, Singarayar S, et al. Balloon warming time is the strongest predictor of late pulmonary vein electrical reconnection following cryoballoon ablation for atrial fibrillation. Heart Rhythm. 2013;10(9):1311–7.
Ciconte G, Mugnai G, Sieira J, Velagic V, Saitoh Y, Irfan G, et al. On the quest for the best freeze: predictors of late pulmonary vein reconnections after second-generation cryoballoon ablation. Circ Arrhythm Electrophysiol. 2015;8(6):1359–65.
Aryana A, Mugnai G, Singh SM, Pujara DK, de Asmundis C, Singh SK, et al. Procedural and biophysical indicators of durable pulmonary vein isolation during cryoballoon ablation of atrial fibrillation. Heart Rhythm. 2016;13(2):424–32.
Aryana A, Kenigsberg DN, Kowalski M, Koo CH, Lim HW, O'Neill PG, et al. Verification of a novel atrial fibrillation cryoablation dosing algorithm guided by time-to-pulmonary vein isolation: results from the Cryo-DOSING Study (Cryoballoon-ablation DOSING Based on the Assessment of Time-to-Effect and Pulmonary Vein Isolation Guidance). Heart Rhythm. 2017;14(9):1319–25.
Su W, Aryana A, Passman R, Singh G, Hokanson R, Kowalski M, et al. Cryoballoon Best Practices II: practical guide to procedural monitoring and dosing during atrial fibrillation ablation from the perspective of experienced users. Heart Rhythm. 2018;15(9):1348–55.
Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation. 2000;102(21):2619–28.
Marrouche NF, Dresing T, Cole C, Bash D, Saad E, Balaban K, et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. J Am Coll Cardiol. 2002;40(3):464–74.
Kuck KH, Brugada J, Furnkranz A, Metzner A, Ouyang F, Chun KR, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374(23):2235–45.
Cardoso R, Mendirichaga R, Fernandes G, Healy C, Lambrakos LK, Viles-Gonzalez JF, et al. Cryoballoon versus radiofrequency catheter ablation in atrial fibrillation: a meta-analysis. J Cardiovasc Electrophysiol. 2016;27(10):1151–9.
Murray MI, Arnold A, Younis M, Varghese S, Zeiher AM. Cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation: a meta-analysis of randomized controlled trials. Clin Res Cardiol. 2018;107(8):658–69.
Chun KRJ, Brugada J, Elvan A, Geller L, Busch M, Barrera A, et al. The impact of cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation on healthcare utilization and costs: an economic analysis from the FIRE AND ICE trial. J Am Heart Assoc. 2017;6(8):e006043.
Andrade JG, Champagne J, Dubuc M, Deyell MW, Verma A, Macle L, et al. Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial. Circulation. 2019;140(22):1779–88.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sulkin, M.S., Meyers, J. (2021). Radiofrequency Versus Cryoablation. In: Efimov, I.R., Ng, F.S., Laughner, J.I. (eds) Cardiac Bioelectric Therapy. Springer, Cham. https://doi.org/10.1007/978-3-030-63355-4_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-63355-4_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-63354-7
Online ISBN: 978-3-030-63355-4
eBook Packages: MedicineMedicine (R0)